Drugs / Horse Chestnut Seed Extract
Horse Chestnut Seed Extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT06872034 | Apr 2025 → Jan 2026 overdue | — | Beijing Jishuitan Hospital | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00213928 Comparator | May 2002 → Sep 2004 | lymphedema | University of Wisconsin, Madison | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Horse Chestnut Seed Extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00213928 ↗ |
| Known as | escin | “The objectives of this study are to evaluate the effectiveness of escin (as horse chestnut seed extract) for arm lymphedema in women following treatment for breast cancer” NCT00213928 ↗ |
| Known as | Venostasin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06872034 ↗ |